Clinical experience of switching patients with severe hemophilia to rVIII-SingleChain or rIX-FP.

Johannes OldenburgSteven W PipeMaria Elisa MancusoRobert KlamrothAbel HassounMartin OlivieriGeorg GoldmannGili KenetWolfgang MiesbachJolana SchmiedlInga Hegemann

Published in: Current medical research and opinion (2022)

The selected patient cases reported here demonstrate that patients may wish to switch factor products for a variety of reasons; therefore, it is critical to understand why patients switch and what they expect from switching.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
early onset
case report
patient reported outcomes